A recent study presented at ENDO 2025 reveals that artificial sweeteners like aspartame and sucralose, commonly found in diet ...

Combing a weight-loss drug and hormone therapy may be the key to shedding pounds.

Adults with congenital adrenal hyperplasia treated with an oral nonsteroidal drug saw continued disease control with reduced ...

Liverpool won the 2024/25 Premier League title with limited options in midfield. Ryan Gravenberch took over No6 duties after ...

In postmenopausal women with overweight or obesity receiving tirzepatide, use of MHT is associated with superior weight loss outcomes.

Sweetener consumption and genetic predisposition are independently associated with the risk for central precocious puberty.

CONMED Corporation (NASDAQ: CNMD) is one of the best undervalued medical device stocks to buy now. On June 12, Needham downgraded CONMED Corporation (NASDAQ:CNMD) to Hold from Buy without a price ...

(HealthDay News) — From 1999 to 2020, obesity-related cancer mortality increased significantly, according to a study presented at ENDO 2025, the annual meeting of the Endocrine Society, held from July ...

Commonly-used sweeteners including aspartame, are added to Diet Coke and products like Extra chewing gum and Muller Light ...

New data shows no increased cardiovascular risk of the osteoporosis drug vs anabolic agents — and even suggests a lower risk.

Research from ENDO 2025 reveals that GLP-1 anti-obesity medications not only aid in weight loss but also improve testosterone ...